Kirsty Duncan visit Miller lab at SickKids Montreal 2017 CAN Social at SfN - Nov 15 6:30 PM - Hard Rock Hotel San Diego Matthew Hill is the 2016 CAN Young Investigator CAN Advocacy contest winners CAN Connection - April 2016 Toronto - CAN2016 meeting impact of neurological disorders in Canada

 

CAN-ACN news

A Novel Treatment May Help Reduce the Progression of Alzheimer’s Disease

Of all the neurodegenerative diseases, Alzheimer’s disease (AD) stands as the most common worldwide. While the onset is complex in nature, a hallmark sign of illness is the accumulation of a particular peptide in the brain, known as amyloid beta (Aβ) (http://www.jci.org/articles/view/25100). When present, the molecule can aggregate to form plaques and also interact with cells in the brain leading to altered signalling and function.

Neuroscience news

Brain cells that aid appetite control identified

Maia Kokoeva

Maia Kokoeva

Discovery opens door to development of new drugs to control weight gain and obesity
It’s rare for scientists to get what they describe as “clean” results without spending a lot of time repeating the same experiment over and over again. But when researchers saw the mice they were working with doubling their weight within a month or two, they knew they were on to something.

Chemical in marijuana shows promise in treating schizophrenia

Laviolette and Renard

Laviolette and Renard

According to new research at Western University, marijuana is the ultimate contradiction; at least when it comes to schizophrenia.

This first-of-its-kind study, published in the Journal of Neuroscience, demonstrates that a chemical found in marijuana called cannabidiol, or CBD, affects the brain in a way that makes it an ideal treatment option for schizophrenia. This research comes just months after the same lab found that adolescent exposure to THC, the other major compound found in marijuana, may lead to the onset of schizophrenia in adulthood.

Mechanism that reduces effect of cocaine on brain discovered

Sarah Konefal, David Stellwagen

Sarah Konefal, David Stellwagen

Finding offers hope for development of a new approach to prevent drug use relapses

A type of brain cell known as microglia plays a key role in reducing the effects of cocaine in the brain, according to a major study by a team from the Research Institute of the McGill University Health Centre (RI-MUHC).

Rapid eye movement sleep: keystone of memory formation

Sylvain Williams

Sylvain Williams

For decades, scientists have fiercely debated whether rapid eye movement (REM) sleep – the phase where dreams appear – is directly involved in memory formation.

Now, a study published in Science by researchers at the Douglas Mental Health University Institute (McGill University) and the University of Bern provides evidence that REM sleep does, indeed, play this role – at least in mice.

What makes the brain tick so fast?

Dr. Derek Bowie

Derek Bowie

New study sheds light on the workings of brain neurotransmitter receptors

Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain’s ability to process information with lightning speed, according to a new study.

Scientists at McGill University, working with collaborators at the universities of Oxford and Liverpool, combined experimental techniques to examine fast-acting protein macromolecules, known as AMPA receptors, which are a major player in brain signaling.  Their findings are reported online in the journal Neuron.